FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted
July 13, 2022 -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Coronavirus | Covid Vaccine | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | General Medicine | Respiratory Medicine | SARS | Vaccines